NCT07210840

Brief Summary

Chronic dizziness is a common and often debilitating condition, especially among older adults. It typically presents as a persistent sensation of unsteadiness, spinning, or motion lasting weeks or months. Most cases stem from vestibular system disorders, such as vestibular neuritis, benign paroxysmal positional vertigo (BPPV), Menière's disease, and bilateral vestibulopathy \[1,2\]. Symptoms may persist beyond the acute phase due to the brain's incomplete adaptation or maladaptive behaviors, like avoiding movement. Psychological factors, such as anxiety and stress, can worsen or prolong symptoms \[3\]. While many vestibular disorders resolve over time, some patients experience chronic symptoms due to poor central compensation or fear-based movement avoidance \[2\]. Chronic dizziness significantly impacts daily life-leading to imbalance, increased fall risk, reduced mobility, and emotional distress. Proper management is crucial to improving safety, independence, and quality of life \[4\]. Initial treatments may include medications or maneuvers like the Epley technique for BPPV. If symptoms persist, Vestibular Rehabilitation Therapy (VRT) is often recommended. VRT is a personalized exercise program aimed at enhancing the brain's ability to adapt, habituate, or compensate through substitution \[6-8\]. Recently, Virtual Reality (VR) has emerged as an innovative tool in vestibular rehab. It provides engaging, interactive environments for practicing balance and visual-vestibular tasks. Studies suggest that VR is feasible, well-tolerated, and effective, particularly for patients with persistent or visually-induced dizziness \[9,10\].

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
19mo left

Started Nov 2025

Typical duration for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress25%
Nov 2025Dec 2027

First Submitted

Initial submission to the registry

September 30, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 7, 2025

Completed
25 days until next milestone

Study Start

First participant enrolled

November 1, 2025

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2026

Expected
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2027

Last Updated

October 7, 2025

Status Verified

September 1, 2025

Enrollment Period

1 year

First QC Date

September 30, 2025

Last Update Submit

September 30, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • cure rate

    the clinical effectiveness of treatment in management of patients with chronic dizziness due to vestibular disorders.

    baseline

Study Arms (2)

Group A

ACTIVE COMPARATOR

Traditional Vestibular Rehabilitation Therapy

Procedure: Traditional Vestibular Rehabilitation Therapy

Group B

ACTIVE COMPARATOR

Virtual Reality treatment

Procedure: Virtual Reality treatment

Interventions

Exercises delivered via a VR system simulating balance tasks and environments

Group B

Customized vestibular exercises (gaze stabilization, balance, habituation, gait training).

Group A

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged 18-70 years.
  • Patients diagnosed with chronic dizziness (duration \>3 months) due to peripheral vestibular disorders (e.g., vestibular neuritis, BPPV, unilateral vestibular hypofunction).

You may not qualify if:

  • Presence of central vestibular disorders (e.g., multiple sclerosis, cerebellar ataxia,
  • stroke).
  • Patients in acute phase
  • Presence of severe visual impairment
  • Presence of motor disabilities that prevent safe participation in rehabilitation exercises.
  • Cognitive impairment or psychiatric illness that decrease ability to follow instructions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
residant doctor at Assiut university hospital

Study Record Dates

First Submitted

September 30, 2025

First Posted

October 7, 2025

Study Start

November 1, 2025

Primary Completion (Estimated)

November 1, 2026

Study Completion (Estimated)

December 1, 2027

Last Updated

October 7, 2025

Record last verified: 2025-09